Predicting Echocardiographic Stage B2 Myxomatous Mitral Valve Disease in Preclinical Cavalier King Charles Spaniels | VETgirl Veterinary Continuing Education Podcasts

VETgirl Veterinary Continuing Education Podcasts

内容由VETgirl Veterinary Continuing Education Podcasts, Dr. Justine Lee, DACVECC, DABT, and Dr. Garret Pachinger提供。所有播客内容（包括剧集、图形和播客描述）均由 VETgirl Veterinary Continuing Education Podcasts, Dr. Justine Lee, DACVECC, DABT, and Dr. Garret Pachinger 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

4M ago 18:40

MP3•单集首页

In today's VETgirl online veterinary CE podcast, we’re going to talk about one of my favorite breeds, the super sweet Cavalier King Charles Spaniel (what we’ll Cavaliers from now on, since it’s a mouthful!). Unfortunately, we all know that this breed has horrible myxomatous mitral valve disease. So, if you see Cavaliers in your clinic, when should you decide to put these dogs on heart medications? After all, we know that the initiation of pimobendan can significantly delay the onset of congestive heart failure in dogs with stage B2 myxomatous mitral valve disease (or “mitral valve disease”), and that detection of the transition from stage B1 to B2 in this population of dogs is important so that therapy can be initiated expediently.
Sponsored By: Antech

906集单集